摘要积极降脂减少终点事件研究（Incremental e—crease in End Points Through Aggressive Lipid Lowering，IDEAL），提示矫正载脂蛋白A（apoA-1）及其他脂蛋白参数后，高密度脂蛋白胆固醇（HDL—C）甚至成了心血管病不良的危险因子，并不起心血管保护指标的作用，
出处《中华高血压杂志》CASCSCD北大核心
2007年第11期966-966,共1页
Chinese Journal of Hypertension
1Gotto AM Jr,Brinton EA.Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary disease:a working group report and update[J].J Am Coll Cardiol,2004,43(5):717.
2van der Westhuyzen DR,de Beer FC,Webb NR.HDL cholesteroltransport during inflammation[J].Curr Opin Lipidol,2007,18(2):147.
3Zheng L,Nukuna B,Brennan ML,et al.Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease[J].J Clin Incest,2004,114(4):529.
4Ansell BJ,Navab M,Hama S,et al.Inflammatory/anti inflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment[J].Circulation,2003,108(22):2751.
5Uzunlulu M,Oguz A,Tigen K.High-density lipoprotein cholesterol in coronary artery disease patients:is it as low as expected[J].Anadolu Kardiyol Derg,2005,5(4):268.
6DeFaria Yeh D,Freeman MV,Meiqs JB,et al.Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol[J].Am J Cardiol,2007,99(1):1.
7Jov T,Heqele RA.Is raising HDL a futile strategy for atheroprotection[J].Nat Rey Drug Discov,2008,7(2):143.
